{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T23:37:09Z","timestamp":1783726629276,"version":"3.55.0"},"reference-count":198,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Evelyn Wyrzykowski Family Professorship in Cardiovascular Sciences"},{"name":"ICS\/BMO"}],"content-domain":{"domain":["www.mdpi.com"],"crossmark-restriction":true},"short-container-title":["IJMS"],"abstract":"<jats:p>Heart failure (HF) represents a major and escalating public health challenge in the aging population. Older adults with HF frequently present with coexisting conditions such as hypertension, diabetes mellitus and obesity, which substantially influence disease pathophysiology, clinical presentation, therapeutic response and prognosis. The complex interplay between HF risk factors and comorbidities complicates diagnosis, limits the applicability of guideline-directed therapies and contributes to increased symptom burden, recurrent hospitalizations, higher healthcare utilization and reduced quality of life. In this Review, we examine the mechanisms through which common risk factors and comorbidities modify HF progression and outcomes in elderly patients, highlighting their impact on disease severity and treatment effectiveness. We emphasize the need for individualized, patient-centered management strategies that move beyond a single-disease framework and incorporate multidisciplinary care models. Early identification of comorbidities tailored pharmacological and non-pharmacological interventions, and longitudinal monitoring are essential to address the dual burden of HF and multimorbidity. Finally, we discuss current knowledge gaps and future research priorities, including the need to elucidate shared pathophysiological pathways and to develop integrated therapeutic approaches. Advancing our understanding of HF in the context of aging and risk factor\/comorbidity is critical for improving clinical outcomes and informing healthcare policy in this growing patient population.<\/jats:p>","DOI":"10.3390\/ijms27125296","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T06:53:10Z","timestamp":1781247190000},"page":"5296","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Impact of Risk Factors and Comorbidities on Heart Failure in the Aging Population"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-2531-7688","authenticated-orcid":false,"given":"Ruzzell C.","family":"Flores","sequence":"first","affiliation":[{"name":"Department of Physiology and Pathophysiology, Rady College of Medicine, Max Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R2H2A6, Canada"},{"name":"The Institute of Cardiovascular Sciences, St. Boniface Hospital Albrechtsen Research Centre, Winnipeg, MB R2H2A6, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatin Shadab","family":"Talukder","sequence":"additional","affiliation":[{"name":"Department of Physiology and Pathophysiology, Rady College of Medicine, Max Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R2H2A6, Canada"},{"name":"The Institute of Cardiovascular Sciences, St. Boniface Hospital Albrechtsen Research Centre, Winnipeg, MB R2H2A6, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5067-8803","authenticated-orcid":false,"given":"Inna","family":"Rabinovich-Nikitin","sequence":"additional","affiliation":[{"name":"Department of Physiology and Pathophysiology, Rady College of Medicine, Max Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R2H2A6, Canada"},{"name":"The Institute of Cardiovascular Sciences, St. Boniface Hospital Albrechtsen Research Centre, Winnipeg, MB R2H2A6, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.cger.2009.07.007","article-title":"The Burden of Cardiovascular Disease in the Elderly: Morbidity, Mortality, and Costs","volume":"25","author":"Yazdanyar","year":"2009","journal-title":"Clin. Geriatr. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"102230","DOI":"10.1016\/j.eclinm.2023.102230","article-title":"Ranking age-specific modifiable risk factors for cardiovascular disease and mortality: Evidence from a population-based longitudinal study","volume":"64","author":"Tian","year":"2023","journal-title":"EClinicalMedicine"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/ehjqcco\/qcad033","article-title":"Burden of cardiovascular disease among elderly: Based on the Global Burden of Disease Study 2019","volume":"10","author":"Qu","year":"2024","journal-title":"Eur. Heart J. Qual. Care Clin. Outcomes"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/ejhf.2115","article-title":"Universal definition and classification of heart failure: A report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: Endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association","volume":"23","author":"Bozkurt","year":"2021","journal-title":"Eur. J. Heart Fail."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"100527","DOI":"10.1016\/j.ajpc.2023.100527","article-title":"The AHA\/ACC\/HFSA 2022 Heart Failure Guidelines: Changing the Focus to Heart Failure Prevention","volume":"15","author":"Abovich","year":"2023","journal-title":"Am. J. Prev. Cardiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.cardfail.2023.07.006","article-title":"Heart Failure Epidemiology and Outcomes Statistics: A Report of the Heart Failure Society of America","volume":"29","author":"Bozkurt","year":"2023","journal-title":"J. Card. Fail."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2174\/011573403X289572240206112303","article-title":"The Interplay of Comorbidities in Chronic Heart Failure: Challenges and Solutions","volume":"20","author":"Agress","year":"2024","journal-title":"Curr. Cardiol. Rev."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1002\/ejhf.1818","article-title":"Trends in prevalence of comorbidities in heart failure clinical trials","volume":"22","author":"Khan","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jchf.2024.02.021","article-title":"Aging in Heart Failure: Embracing Biology Over Chronology: JACC Family Series","volume":"12","author":"Goyal","year":"2024","journal-title":"JACC Heart Fail."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.jacc.2019.06.053","article-title":"Cardiovascular Aging and Heart Failure: JACC Review Topic of the Week","volume":"74","author":"Triposkiadis","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.ijcard.2012.11.065","article-title":"Worldwide risk factors for heart failure: A systematic review and pooled analysis","volume":"168","author":"Khatibzadeh","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1093\/cvr\/cvz035","article-title":"Common risk factors for heart failure and cancer","volume":"115","author":"Meijers","year":"2019","journal-title":"Cardiovasc. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1527-5299.2003.00271.x","article-title":"Management of arrhythmias in heart failure","volume":"9","author":"Ellison","year":"2003","journal-title":"Congest. Heart Fail."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1002\/ejhf.821","article-title":"Associations with and prognostic impact of chronic kidney disease in heart failure with preserved, mid-range, and reduced ejection fraction","volume":"19","author":"Szummer","year":"2017","journal-title":"Eur. J. Heart Fail."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"van de Wouw, J., Broekhuizen, M., Sorop, O., Joles, J.A., Verhaar, M.C., Duncker, D.J., Danser, A.H.J., and Merkus, D. (2019). Chronic Kidney Disease as a Risk Factor for Heart Failure with Preserved Ejection Fraction: A Focus on Microcirculatory Factors and Therapeutic Targets. Front. Physiol., 10.","DOI":"10.3389\/fphys.2019.01108"},{"key":"ref_16","first-page":"305","article-title":"The association between COPD and heart failure risk: A review","volume":"8","author":"Morgan","year":"2013","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1093\/cvr\/cvae240","article-title":"Inflammageing, a targetable pathway for preventing cardiovascular diseases","volume":"121","author":"Aranda","year":"2025","journal-title":"Cardiovasc. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s11897-017-0337-9","article-title":"Inflammation-Cause or Consequence of Heart Failure or Both?","volume":"14","year":"2017","journal-title":"Curr. Heart Fail. Rep."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Amara, M., Stoler, O., and Birati, E.Y. (2025). The Role of Inflammation in the Pathophysiology of Heart Failure. Cells, 14.","DOI":"10.3390\/cells14141117"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Javaheri, S., and Javaheri, S. (2022). Obstructive Sleep Apnea in Heart Failure: Current Knowledge and Future Directions. J. Clin. Med., 11.","DOI":"10.3390\/jcm11123458"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11883-008-0017-z","article-title":"Alcohol consumption and heart failure: A systematic review","volume":"10","author":"Gaziano","year":"2008","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1161\/CIR.0000000000001341","article-title":"Alcohol Use and Cardiovascular Disease: A Scientific Statement from the American Heart Association","volume":"152","author":"Piano","year":"2025","journal-title":"Circulation"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00059-022-05123-9","article-title":"Comorbidities in heart failure with preserved ejection fraction","volume":"47","author":"Deichl","year":"2022","journal-title":"Herz"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.21037\/jtd-22-833","article-title":"Association between comorbid cardiomyopathy and composite endpoints of patients with congestive heart failure in the intensive care unit: A retrospective cohort study","volume":"14","author":"Liang","year":"2022","journal-title":"J. Thorac. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e535","DOI":"10.1161\/CIR.0000000000000450","article-title":"Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement from the American Heart Association","volume":"134","author":"Bozkurt","year":"2016","journal-title":"Circulation"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Scholten, M., Davidge, J., Agvall, B., and Halling, A. (2024). Comorbidities in heart failure patients that predict cardiovascular readmissions within 100 days-An observational study. PLoS ONE, 19.","DOI":"10.1371\/journal.pone.0296527"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"E56","DOI":"10.1161\/CIR.0000000000000988","article-title":"Obstructive Sleep Apnea and Cardiovascular Disease: A Scientific Statement from the American Heart Association","volume":"144","author":"Yeghiazarians","year":"2021","journal-title":"Circulation"},{"key":"ref_28","first-page":"101197","article-title":"Current Landscape and Future Directions of Coronary Revascularization in Ischemic Systolic Heart Failure: A Review","volume":"2","author":"Chuy","year":"2023","journal-title":"J. Soc. Cardiovasc. Angiogr. Interv."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"188","DOI":"10.31083\/j.rcm2306188","article-title":"Risk Factors and Cardiovascular Disease in the Elderly","volume":"23","author":"Bonanad","year":"2022","journal-title":"Rev. Cardiovasc. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"n461","DOI":"10.1136\/bmj.n461","article-title":"Age dependent associations of risk factors with heart failure: Pooled population based cohort study","volume":"372","author":"Tromp","year":"2021","journal-title":"BMJ"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/ejhf.30","article-title":"Co-morbidities in patients with heart failure: An analysis of the European Heart Failure Pilot Survey","volume":"16","author":"Urso","year":"2014","journal-title":"Eur. J. Heart Fail."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.jchf.2019.09.004","article-title":"Impact of Age on Comorbidities and Outcomes in Heart Failure with Reduced Ejection Fraction","volume":"7","author":"Regan","year":"2019","journal-title":"JACC Heart Fail"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/jgs.12062","article-title":"Patterns of comorbidity in older adults with heart failure: The Cardiovascular Research Network PRESERVE study","volume":"61","author":"Saczynski","year":"2013","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Lee, K.S., Park, D.I., Lee, J., Oh, O., Kim, N., and Nam, G. (2023). Relationship between comorbidity and health outcomes in patients with heart failure: A systematic review and meta-analysis. BMC Cardiovasc. Disord., 23.","DOI":"10.1186\/s12872-023-03527-x"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e07","DOI":"10.15420\/cfr.2021.29","article-title":"The Impact of Frailty and Comorbidities on Heart Failure Outcomes","volume":"8","author":"Salmon","year":"2022","journal-title":"Card. Fail. Rev."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jacc.2011.11.040","article-title":"Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction","volume":"59","author":"Ather","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1016\/j.jacc.2023.03.426","article-title":"Uptitrating Treatment After Heart Failure Hospitalization Across the Spectrum of Left Ventricular Ejection Fraction","volume":"81","author":"Pagnesi","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"E225982","DOI":"10.1001\/jamanetworkopen.2022.5982","article-title":"Effectiveness and Cost-effectiveness of an Empowerment-Based Self-care Education Program on Health Outcomes Among Patients with Heart Failure: A Randomized Clinical Trial","volume":"5","author":"Yu","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0140-6736(24)01643-X","article-title":"Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: A pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials","volume":"404","author":"Kosiborod","year":"2024","journal-title":"Lancet"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Horvat, M., Er\u017een, I., and Vrbnjak, D. (2024). Barriers and Facilitators to Medication Adherence among the Vulnerable Elderly: A Focus Group Study. Healthcare, 12.","DOI":"10.3390\/healthcare12171723"},{"key":"ref_41","first-page":"e79590","article-title":"Barriers to Implementing Effective Healthcare Practices for the Aging Population: Approaches to Identification and Management","volume":"17","author":"Theodorakis","year":"2025","journal-title":"Cureus"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1001\/jama.294.4.466","article-title":"Hypertension in adults across the age spectrum: Current outcomes and control in the community","volume":"294","author":"Evans","year":"2005","journal-title":"JAMA"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1161\/01.CIR.103.9.1245","article-title":"Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study","volume":"103","author":"Franklin","year":"2001","journal-title":"Circulation"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jchf.2019.08.020","article-title":"Healthy Aging and Cardiovascular Function: Invasive Hemodynamics During Rest and Exercise in 104 Healthy Volunteers","volume":"8","author":"Pandey","year":"2020","journal-title":"JACC Heart Fail."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1749-6632.2002.tb02086.x","article-title":"The role of apoptosis in the normal aging brain, skeletal muscle, and heart","volume":"959","author":"Pollack","year":"2002","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/jhh.2011.73","article-title":"Aortic stiffness; inflammation, denutrition and prognosis in the oldest people","volume":"26","author":"Blacher","year":"2012","journal-title":"J. Hum. Hypertens."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.hrtlng.2020.03.023","article-title":"Epidemiology and clinical characteristics of hospitalized elderly patients for heart failure with reduced, mid-range and preserved ejection fraction","volume":"49","author":"Sinan","year":"2020","journal-title":"Heart Lung"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e000782","DOI":"10.1136\/openhrt-2018-000782","article-title":"Risk factors for incident heart failure with preserved or reduced ejection fraction, and valvular heart failure, in a community-based cohort","volume":"5","author":"Gong","year":"2018","journal-title":"Open Heart"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1093\/eurheartj\/eht066","article-title":"Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND","volume":"34","author":"Brouwers","year":"2013","journal-title":"Eur. Heart J."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1080\/14017431.2017.1311023","article-title":"Prevalence of heart failure in the elderly and future projections: The AGES-Reykjav\u00edk study","volume":"51","author":"Danielsen","year":"2017","journal-title":"Scand. Cardiovasc. J."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/eurjhf\/hfs052","article-title":"Prevalence of preclinical and clinical heart failure in the elderly. A population-based study in Central Italy","volume":"14","author":"Mureddu","year":"2012","journal-title":"Eur. J. Heart Fail."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jchf.2022.06.012","article-title":"Trends in Heart Failure-Related Mortality Among Older Adults in the United States from 1999\u20132019","volume":"10","author":"Siddiqi","year":"2022","journal-title":"JACC Heart Fail."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jcgg.2014.10.002","article-title":"Impact on mortality of systolic and\/or diastolic heart failure in the elderly\u201410 years of follow-up","volume":"6","author":"Olofsson","year":"2015","journal-title":"J. Clin. Gerontol. Geriatr."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e000840","DOI":"10.1136\/openhrt-2018-000840","article-title":"Prevalence of early stages of heart failure in an elderly risk population: The Copenhagen Heart Failure Risk Study","volume":"6","author":"Gaborit","year":"2019","journal-title":"Open Heart"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1161\/CIRCULATIONAHA.106.666818","article-title":"Prevalence and prognostic significance of heart failure stages: Application of the American College of Cardiology\/American Heart Association heart failure staging criteria in the community","volume":"115","author":"Ammar","year":"2007","journal-title":"Circulation"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/ejhf.980","article-title":"Circulating proteins as predictors of incident heart failure in the elderly","volume":"20","author":"Stenemo","year":"2018","journal-title":"Eur. J. Heart Fail."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e021660","DOI":"10.1161\/JAHA.121.021660","article-title":"Coronary Artery Disease and Heart Failure with Preserved Ejection Fraction: The ARIC Study","volume":"11","author":"John","year":"2022","journal-title":"J. Am. Heart Assoc."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e005253","DOI":"10.1161\/JAHA.116.005253","article-title":"Progression of Coronary Artery Calcium and Incident Heart Failure: The Multi-Ethnic Study of Atherosclerosis","volume":"6","author":"Bakhshi","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/j.amjcard.2017.07.089","article-title":"Usefulness of Coronary Artery Calcium to Predict Heart Failure with Preserved Ejection Fraction in Men Versus Women (from the Multi-Ethnic Study of Atherosclerosis)","volume":"120","author":"Sharma","year":"2017","journal-title":"Am. J. Cardiol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"e037915","DOI":"10.1161\/JAHA.124.037915","article-title":"Coronary Artery Disease Doubles Excess Mortality in Patients with Heart Failure with Reduced Ejection Fraction","volume":"14","author":"Anker","year":"2025","journal-title":"J. Am. Heart Assoc."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1161\/CIRCHEARTFAILURE.114.002024","article-title":"Clinical Characteristics and Outcomes of Patients with Coronary Artery Disease and Angina: Analysis of the Irbesartan in Patients with Heart Failure and Preserved Systolic Function Trial","volume":"8","author":"Badar","year":"2015","journal-title":"Circ. Heart Fail."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"e033938","DOI":"10.1161\/JAHA.123.033938","article-title":"Coronary Artery Disease Is A Stronger Predictor of All-Cause Mortality Than Left Ventricular Ejection Fraction Among Patients with Newly Diagnosed Heart Failure: Insights from the WDHR","volume":"13","author":"Nielsen","year":"2024","journal-title":"J. Am. Heart Assoc."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"E006963","DOI":"10.1161\/CIRCHEARTFAILURE.120.006963","article-title":"Testing for Coronary Artery Disease in Older Patients with New-Onset Heart Failure: Findings from Get with The Guidelines-Heart Failure","volume":"13","author":"Brophy","year":"2020","journal-title":"Circ. Heart Fail."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s11606-023-08599-1","article-title":"Association Between Coronary Artery Disease Testing in Patients with New-Onset Heart Failure and Heart Failure Readmission and Mortality","volume":"39","author":"Huang","year":"2024","journal-title":"J. Gen. Intern. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jacc.2021.11.061","article-title":"Variability in Coronary Artery Disease Testing for Patients with New-Onset Heart Failure","volume":"79","author":"Zheng","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1161\/CIRCULATIONAHA.119.039609","article-title":"Rivaroxaban with or Without Aspirin in Patients with Heart Failure and Chronic Coronary or Peripheral Artery Disease","volume":"140","author":"Branch","year":"2019","journal-title":"Circulation"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jchf.2013.04.012","article-title":"The STICH trial (surgical treatment for ischemic heart failure): Mode-of-death results","volume":"1","author":"Carson","year":"2013","journal-title":"JACC Heart Fail"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/01.CIR.93.5.841","article-title":"Report of the 1995 World Health Organization\/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies","volume":"93","author":"Richardson","year":"1996","journal-title":"Circulation"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s11886-025-02306-8","article-title":"Cardiomyopathy in Older Adults","volume":"27","author":"Forman","year":"2025","journal-title":"Curr. Cardiol. Rep."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"36280","DOI":"10.31083\/RCM36280","article-title":"Classification; Diagnosis, and Prognosis of Cardiomyopathy: A Comprehensive Narrative Review","volume":"26","author":"Jin","year":"2025","journal-title":"Rev. Cardiovasc. Med."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"e107586","DOI":"10.1016\/j.vph.2026.107586","article-title":"Therapeutic perspective on cardiomyopathy and heart failure in older adults through the lens of chronic inflammation","volume":"162","author":"Qiu","year":"2026","journal-title":"Vasc. Pharmacol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1136\/heartjnl-2021-320181","article-title":"Epidemiology of cardiomyopathies and incident heart failure in a population-based cohort study","volume":"108","author":"Brownrigg","year":"2022","journal-title":"Heart"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1159\/000528072","article-title":"Age, GFR, and Ejection Fraction Score as a Good Predictor of Prognosis in Elderly Patients with Nonischemic Dilated Cardiomyopathy","volume":"69","author":"Li","year":"2023","journal-title":"Gerontology"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.ihj.2020.07.016","article-title":"Long-term outcomes of non-ischemic dilated cardiomyopathy patients with left ventricular ejection fraction \u2264 19% on medical therapy","volume":"72","author":"Agstam","year":"2020","journal-title":"Indian Heart J."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/adc.73.5.447","article-title":"Heart transplantation for dilated cardiomyopathy","volume":"73","author":"Adwani","year":"1995","journal-title":"Arch. Dis. Child."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.amjcard.2004.03.007","article-title":"Prevalence of hypertrophic cardiomyopathy in a population-based sample of American Indians aged 51 to 77 years (the Strong Heart Study)","volume":"93","author":"Maron","year":"2004","journal-title":"Am. J. Cardiol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0735-1097(03)00855-6","article-title":"Clinical course of hypertrophic cardiomyopathy with survival to advanced age","volume":"42","author":"Maron","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1253\/circj.CJ-23-0418","article-title":"Hypertrophic Cardiomyopathy Predicts Thromboembolism and Heart Failure in Patients with Nonvalvular Atrial Fibrillation\u2014A Prospective Analysis from the Hokuriku-Plus AF Registry","volume":"87","author":"Tsuda","year":"2023","journal-title":"Circ. J."},{"key":"ref_79","first-page":"196","article-title":"Hypertrophic cardiomyopathy in older patients","volume":"10","author":"Sado","year":"2010","journal-title":"Clin. Med. J. R. Coll. Physicians Lond."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"e018527","DOI":"10.1161\/JAHA.120.018527","article-title":"Characteristics and Outcomes of Elderly Patients with Hypertrophic Cardiomyopathy","volume":"10","author":"Alashi","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1161\/CIRCULATIONAHA.115.018852","article-title":"Heart Failure Resulting from Age-Related Cardiac Amyloid Disease Associated with Wild-Type Transthyretin: A Prospective, Observational Cohort Study","volume":"133","author":"Connors","year":"2016","journal-title":"Circulation"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.cardfail.2024.02.014","article-title":"Temporal Outcomes of Patients Diagnosed with Transthyretin Cardiac Amyloidosis","volume":"30","author":"Chan","year":"2024","journal-title":"J. Card. Fail."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1080\/07853890701842988","article-title":"Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation in alpha2-macroglobulin and tau: A population-based autopsy study","volume":"40","author":"Tanskanen","year":"2008","journal-title":"Ann. Med."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Porcari, A., Bussani, R., Merlo, M., Varr\u00e0, G.G., Pagura, L., Rozze, D., and Sinagra, G. (2021). Incidence and Characterization of Concealed Cardiac Amyloidosis Among Unselected Elderly Patients Undergoing Post-mortem Examination. Front. Cardiovasc. Med., 8.","DOI":"10.3389\/fcvm.2021.749523"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jacc.2016.06.033","article-title":"Natural History of Wild-Type Transthyretin Cardiac Amyloidosis and Risk Stratification Using a Novel Staging System","volume":"68","author":"Grogan","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"e042330","DOI":"10.1161\/JAHA.125.042330","article-title":"Tafamidis Reduces Death and Hospitalization for Acute Heart Failure in Octogenarian Patients with Transthyretin Cardiac Amyloidosis: A Propensity Score-Weighted Cohort Study","volume":"14","author":"Zmuda","year":"2025","journal-title":"J. Am. Heart Assoc."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jjcc.2008.06.001","article-title":"Improvement in prognosis of dilated cardiomyopathy in the elderly over the past 20 years","volume":"52","author":"Kubo","year":"2008","journal-title":"J. Cardiol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(20)31792-X","article-title":"Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): A randomised, double-blind, placebo-controlled, phase 3 trial","volume":"396","author":"Olivotto","year":"2020","journal-title":"Lancet"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/ehf2.13144","article-title":"Heart failure after myocardial infarction: Incidence and predictors","volume":"8","author":"Stehlik","year":"2021","journal-title":"ESC Heart Fail."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1111\/jcmm.16329","article-title":"Mangiferin prevents myocardial infarction-induced apoptosis and heart failure in mice by activating the Sirt1\/FoxO3a pathway","volume":"25","author":"Chen","year":"2021","journal-title":"J. Cell. Mol. Med."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13062-022-00338-6","article-title":"Alamandine alleviated heart failure and fibrosis in myocardial infarction mice","volume":"17","author":"Zhao","year":"2022","journal-title":"Biol. Direct"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1002\/ejhf.3788","article-title":"Association between antecedent myocardial infarction and heart failure with preserved versus reduced ejection fraction","volume":"27","author":"Almesned","year":"2025","journal-title":"Eur. J. Heart Fail."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1093\/eurheartj\/ehn267","article-title":"The effect of ageing on cardiac remodelling and hospitalization for heart failure after an inaugural anterior myocardial infarction","volume":"29","author":"Ennezat","year":"2008","journal-title":"Eur. Heart J."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jacc.2008.08.067","article-title":"Declining in-hospital mortality and increasing heart failure incidence in elderly patients with first myocardial infarction","volume":"53","author":"Ezekowitz","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"e002667","DOI":"10.1161\/JAHA.115.002667","article-title":"Heart Failure Complicating Acute Myocardial Infarction; Burden and Timing of Occurrence: A Nation-wide Analysis Including 86 771 Patients from the Cardiovascular Disease in Norway (CVDNOR) Project","volume":"5","author":"Sulo","year":"2016","journal-title":"J. Am. Heart Assoc."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1161\/CIRCHEARTFAILURE.112.968180","article-title":"Risk of heart failure complication during hospitalization for acute myocardial infarction in a contemporary population: Insights from the National Cardiovascular Data ACTION Registry","volume":"5","author":"Shah","year":"2012","journal-title":"Circ. Heart Fail."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1136\/hrt.2009.191742","article-title":"Unrecognised myocardial infarction and long-term risk of heart failure in the elderly: The Rotterdam Study","volume":"96","author":"Leening","year":"2010","journal-title":"Heart"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1253\/circrep.CR-22-0048","article-title":"Outcomes of Elderly Patients with Acute Myocardial Infarction and Heart Failure Who Undergo Percutaneous Coronary Intervention","volume":"4","author":"Nishihira","year":"2022","journal-title":"Circ. Rep."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"E37381","DOI":"10.1097\/MD.0000000000037381","article-title":"Application of intensive management of risk awareness combined with cardiac rehabilitation nursing in elderly patients with acute myocardial infarction and heart failure","volume":"103","author":"Yin","year":"2024","journal-title":"Medicine"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12968-020-00655-7","article-title":"Progression and regression of left ventricular hypertrophy and myocardial fibrosis in a mouse model of hypertension and concomitant cardiomyopathy","volume":"22","author":"Kwiecinski","year":"2020","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jacc.2009.07.059","article-title":"The Hypertensive Heart: An Integrated Understanding Informed by Imaging","volume":"55","author":"Raman","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_102","first-page":"CD012039","article-title":"Pharmacotherapy for hypertension-induced left ventricular hypertrophy","volume":"10","author":"Leache","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Zhang, H., Singal, P.K., Ravandi, A., and Rabinovich-Nikitin, I. (2025). Sex-Specific Differences in the Pathophysiology of Hypertension. Biomolecules, 15.","DOI":"10.3390\/biom15010143"},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Gallo, G., and Savoia, C. (2024). Hypertension and Heart Failure: From Pathophysiology to Treatment. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25126661"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/ejhf.427","article-title":"Incidence of heart failure in 6083 elderly hypertensive patients: The Second Australian National Blood Pressure Study (ANBP2)","volume":"18","author":"Sahle","year":"2016","journal-title":"Eur. J. Heart Fail."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1136\/hrt.2011.225482","article-title":"Systolic blood pressure and incident heart failure in the elderly. The Cardiovascular Health Study and the Health, Ageing and Body Composition Study","volume":"97","author":"Butler","year":"2011","journal-title":"Heart"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"5493","DOI":"10.1002\/ehf2.13650","article-title":"Prognostic impact of systolic blood pressure in acute heart failure with preserved ejection fraction in older patients","volume":"8","author":"Putot","year":"2021","journal-title":"ESC Heart Fail."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3892\/etm.2016.3302","article-title":"Therapeutic effects of intravenous urapidil in elderly patients with hypertension and acute decompensated heart failure: A pilot clinical trial","volume":"12","author":"Yang","year":"2016","journal-title":"Exp. Ther. Med."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ijcard.2022.09.050","article-title":"Effectiveness and safety evaluation of sacubitril\/valsartan in blood pressure control and clinical outcomes for elderly patients with heart failure and hypertension: A prospective cohort study","volume":"371","author":"Li","year":"2023","journal-title":"Int. J. Cardiol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"e70035","DOI":"10.1111\/anec.70035","article-title":"Association Between Different Insulin Resistance Indices and Heart Failure in US Adults with Diabetes Mellitus","volume":"29","author":"Chen","year":"2024","journal-title":"Ann. Noninvasive Electrocardiol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12967-023-03928-8","article-title":"Role of mitochondrial metabolic disorder and immune infiltration in diabetic cardiomyopathy: New insights from bioinformatics analysis","volume":"21","author":"Peng","year":"2023","journal-title":"J. Transl. Med."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1007\/s00125-023-06068-2","article-title":"Epidemiology of heart failure in diabetes: A disease in disguise","volume":"67","author":"Hoek","year":"2024","journal-title":"Diabetologia"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1007\/s00125-012-2579-0","article-title":"High prevalence of previously unknown heart failure and left ventricular dysfunction in patients with type 2 diabetes","volume":"55","author":"Rutten","year":"2012","journal-title":"Diabetologia"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ahj.2016.07.025","article-title":"Temporal trends and factors associated with diabetes mellitus among patients hospitalized with heart failure: Findings from Get with The Guidelines-Heart Failure registry","volume":"182","author":"Xu","year":"2016","journal-title":"Am. Heart J."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/j.amjcard.2008.02.082","article-title":"Association Between Diabetes Mellitus and Left Ventricular Hypertrophy in a Multi-Ethnic Population","volume":"101","author":"Eguchi","year":"2008","journal-title":"Am. J. Cardiol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/eurheartj\/eht193","article-title":"Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in diabetes and associated with mortality and incident heart failure admission","volume":"35","author":"Wong","year":"2014","journal-title":"Eur. Heart J."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2337\/db15-0627","article-title":"Relationship Between Left Ventricular Structural and Metabolic Remodeling in Type 2 Diabetes","volume":"65","author":"Levelt","year":"2016","journal-title":"Diabetes"},{"key":"ref_118","first-page":"1390","article-title":"Diagnosis of Nonischemic Stage B Heart Failure in Type 2 Diabetes Mellitus: Optimal Parameters for Prediction of Heart Failure, JACC Cardiovasc","volume":"11","author":"Wang","year":"2018","journal-title":"Imaging"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S2213-8587(15)00292-2","article-title":"Long-term excess risk of heart failure in people with type 1 diabetes: A prospective case-control study","volume":"3","author":"Rosengren","year":"2015","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.2337\/dc19-2541","article-title":"Association of Long-term Change and Variability in Glycemia with Risk of Incident Heart Failure Among Patients with Type 2 Diabetes: A Secondary Analysis of the ACCORD Trial","volume":"43","author":"Segar","year":"2020","journal-title":"Diabetes Care"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1016\/j.ijcard.2013.05.038","article-title":"Prediabetes is not an independent risk factor for incident heart failure, other cardiovascular events or mortality in older adults: Findings from a population-based cohort study","volume":"168","author":"Deedwania","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1161\/CIRCULATIONAHA.119.040130","article-title":"Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus","volume":"139","author":"Kato","year":"2019","journal-title":"Circulation"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1161\/CIRCULATIONAHA.108.807289","article-title":"Body mass index and vigorous physical activity and the risk of heart failure among men","volume":"119","author":"Kenchaiah","year":"2009","journal-title":"Circulation"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa2410027","article-title":"Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity","volume":"392","author":"Packer","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"e033521","DOI":"10.1161\/JAHA.123.033521","article-title":"Obesity and Risk of Incident Left Ventricular Hypertrophy in Community-Dwelling Populations with Hypertension: An Observational Study","volume":"13","author":"Cai","year":"2024","journal-title":"J. Am. Heart Assoc."},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Cobos-Palacios, L., Ruiz-Moreno, M.I., Vilches-Perez, A., Vargas-Candela, A., Mu\u00f1oz-\u00dabeda, M., Porres, J.B., Navarro-Sanz, A., Lopez-Carmona, M.D., Sanz-Canovas, J., and Perez-Belmonte, L.M. (2022). Metabolically healthy obesity: Inflammatory biomarkers and adipokines in elderly population. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0265362"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.jchf.2018.05.018","article-title":"The Association of Obesity and Cardiometabolic Traits with Incident HFpEF and HFrEF","volume":"6","author":"Savji","year":"2018","journal-title":"JACC Heart Fail."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.jacc.2010.10.042","article-title":"Effect of obesity and overweight on left ventricular diastolic function: A community-based study in an elderly cohort","volume":"57","author":"Russo","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/eurheartj\/ehi506","article-title":"Long-term cardiovascular consequences of obesity: 20-year follow-up of more than 15 000 middle-aged men and women (the Renfrew-Paisley study)","volume":"27","author":"Murphy","year":"2006","journal-title":"Eur. Heart J."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/ejhf.534","article-title":"Exercise tolerance can explain the obesity paradox in patients with systolic heart failure: Data from the MECKI Score Research Group","volume":"18","author":"Piepoli","year":"2016","journal-title":"Eur. J. Heart Fail."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1111\/j.1532-5415.2010.02979.x","article-title":"Waist circumference but not body mass index predicts long-term mortality in elderly subjects with chronic heart failure","volume":"58","author":"Testa","year":"2010","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1001\/jama.2015.17346","article-title":"Effect of Caloric Restriction or Aerobic Exercise Training on Peak Oxygen Consumption and Quality of Life in Obese Older Patients with Heart Failure with Preserved Ejection Fraction: A Randomized Clinical Trial","volume":"315","author":"Kitzman","year":"2016","journal-title":"JAMA"},{"key":"ref_133","first-page":"E010161","article-title":"Controlled Trial of Resistance Training Added to Caloric Restriction Plus Aerobic Exercise Training in Obese Heart Failure with Preserved Ejection Fraction","volume":"16","author":"Brubaker","year":"2023","journal-title":"Circ. Heart Fail."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.jchf.2018.06.002","article-title":"Regional Adipose Distribution and its Relationship to Exercise Intolerance in Older Obese Patients Who Have Heart Failure with Preserved Ejection Fraction","volume":"6","author":"Haykowsky","year":"2018","journal-title":"JACC Heart Fail"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1161\/CIRCULATIONAHA.116.025629","article-title":"Weight Loss and Heart Failure: A Nationwide Study of Gastric Bypass Surgery Versus Intensive Lifestyle Treatment","volume":"135","author":"Bruze","year":"2017","journal-title":"Circulation"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jchf.2023.01.008","article-title":"Atrial Fibrillation Ablation for Heart Failure with Preserved Ejection Fraction: A Randomized Controlled Trial","volume":"11","author":"Chieng","year":"2023","journal-title":"JACC Heart Fail."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.jacc.2020.07.009","article-title":"Atrial Dysfunction in Patients with Heart Failure with Preserved Ejection Fraction and Atrial Fibrillation","volume":"76","author":"Reddy","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/j.jacc.2024.07.023","article-title":"Heart Failure Risk Assessment Using Biomarkers in Patients with Atrial Fibrillation: Analysis from COMBINE-AF","volume":"84","author":"Haller","year":"2024","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.115.018614","article-title":"Atrial Fibrillation Begets Heart Failure and Vice Versa: Temporal Associations and Differences in Preserved Versus Reduced Ejection Fraction","volume":"133","author":"Santhanakrishnan","year":"2016","journal-title":"Circulation"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1002\/ehf2.12525","article-title":"In-hospital ventricular arrhythmia in heart failure patients: 7 year follow-up of the multi-centric HEARTS registry","volume":"6","author":"Alenazy","year":"2019","journal-title":"ESC Heart Fail."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jacep.2020.11.021","article-title":"Atrial Fibrillation Burden and Clinical Outcomes in Heart Failure: The CASTLE-AF Trial","volume":"7","author":"Brachmann","year":"2021","journal-title":"JACC Clin. Electrophysiol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.jacc.2024.08.023","article-title":"Atrial Fibrillation and Semaglutide Effects in Obesity-Related Heart Failure with Preserved Ejection Fraction: STEP-HFpEF Program","volume":"84","author":"Verma","year":"2024","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cardfail.2021.10.007","article-title":"Ten-Year Risk-Prediction Equations for Incident Heart Failure Hospitalizations in Chronic Kidney Disease: Findings from the Chronic Renal Insufficiency Cohort Study and the Multi-Ethnic Study of Atherosclerosis","volume":"28","author":"Mehta","year":"2022","journal-title":"J. Card. Fail."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/ejhf.3210","article-title":"Identification and outcomes of KDIGO-defined chronic kidney disease in 1.4 million U.S. Veterans with heart failure","volume":"26","author":"Patel","year":"2024","journal-title":"Eur. J. Heart Fail."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"100705","DOI":"10.1016\/j.xkme.2023.100705","article-title":"Heart Failure with Preserved Ejection Fraction with CKD: A Narrative Review of a Multispecialty Disorder","volume":"5","author":"Patel","year":"2023","journal-title":"Kidney Med."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.amjcard.2020.12.012","article-title":"The Chronic Kidney Disease Phenotype of HFpEF: Unique Cardiac Characteristics","volume":"142","author":"Kirkman","year":"2021","journal-title":"Am. J. Cardiol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jchf.2023.01.029","article-title":"Chronic Kidney Disease, Heart Failure, and Adverse Cardiac Remodeling in Older Adults: The ARIC Study","volume":"11","author":"Buckley","year":"2023","journal-title":"JACC Heart Fail."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1016\/j.jacc.2019.02.071","article-title":"Burden and Outcomes of Heart Failure Hospitalizations in Adults with Chronic Kidney Disease","volume":"73","author":"Bansal","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.jacc.2024.08.004","article-title":"Effects of Semaglutide on Heart Failure Outcomes in Diabetes and Chronic Kidney Disease in the FLOW Trial","volume":"84","author":"Pratley","year":"2024","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.jchf.2022.07.013","article-title":"Finerenone and Heart Failure Outcomes by Kidney Function\/Albuminuria in Chronic Kidney Disease and Diabetes","volume":"10","author":"Filippatos","year":"2022","journal-title":"JACC Heart Fail."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/j.jacc.2025.03.009","article-title":"Interplay of Chronic Kidney Disease and the Effects of Tirzepatide in Patients with Heart Failure, Preserved Ejection Fraction, and Obesity: The SUMMIT Trial","volume":"85","author":"Packer","year":"2025","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ijcard.2013.10.068","article-title":"Clinical profiles and outcomes in patients with chronic heart failure and chronic obstructive pulmonary disease: An efficacy and safety analysis of SHIFT study","volume":"170","author":"Tavazzi","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"106800","DOI":"10.1016\/j.rmed.2022.106800","article-title":"Heart failure in patients with COPD exacerbations: Looking below the tip of the iceberg","volume":"196","author":"Hesse","year":"2022","journal-title":"Respir. Med."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"e108381","DOI":"10.1016\/j.rmed.2025.108381","article-title":"Clinical and economic impact of concomitant heart failure in patients with exacerbated COPD","volume":"248","author":"Escudero","year":"2025","journal-title":"Respir. Med."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/ehf2.14958","article-title":"Association of COPD with adverse outcomes in heart failure patients with preserved ejection fraction","volume":"12","author":"Xu","year":"2025","journal-title":"ESC Heart Fail."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"e021494","DOI":"10.1161\/JAHA.121.021494","article-title":"Impact of Chronic Obstructive Pulmonary Disease in Patients with Heart Failure with Preserved Ejection Fraction: Insights from PARAGON-HF","volume":"10","author":"Mooney","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1002\/ejhf.3000","article-title":"Heart failure, chronic obstructive pulmonary disease and efficacy and safety of dapagliflozin in heart failure with mildly reduced or preserved ejection fraction: Insights from DELIVER","volume":"25","author":"Butt","year":"2023","journal-title":"Eur. J. Heart Fail."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/ejhf.2083","article-title":"Effects of dapagliflozin in heart failure with reduced ejection fraction and chronic obstructive pulmonary disease: An analysis of DAPA-HF","volume":"23","author":"Dewan","year":"2021","journal-title":"Eur. J. Heart Fail."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1002\/ejhf.70046","article-title":"Beta-blockers in patients with heart failure with reduced ejection fraction and concomitant chronic obstructive pulmonary disease: Cardiovascular and respiratory outcomes","volume":"27","author":"Beer","year":"2025","journal-title":"Eur. J. Heart Fail."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1002\/acr.24804","article-title":"Association Between Inflammation, Incident Heart Failure, and Heart Failure Subtypes in Patients with Rheumatoid Arthritis","volume":"75","author":"Huang","year":"2023","journal-title":"Arthritis Care Res."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"e014661","DOI":"10.1161\/JAHA.119.014661","article-title":"Heart Failure Risk Associated with Rheumatoid Arthritis-Related Chronic Inflammation","volume":"9","author":"Ahlers","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.jacc.2009.12.045","article-title":"Inflammatory Markers and Incident Heart Failure Risk in Older Adults. The Health ABC (Health, Aging, and Body Composition) Study","volume":"55","author":"Kalogeropoulos","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"131400","DOI":"10.1016\/j.ijcard.2023.131400","article-title":"Associations between systemic immunity-inflammation index and heart failure: Evidence from the NHANES 1999\u20132018","volume":"395","author":"Zheng","year":"2024","journal-title":"Int. J. Cardiol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/ejhf.2767","article-title":"Quantifying inflammation using interleukin-6 for improved phenotyping and risk stratification in acute heart failure","volume":"25","author":"Michou","year":"2023","journal-title":"Eur. J. Heart Fail."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s10557-020-07071-0","article-title":"Inflammatory Cytokines and Chemokines as Therapeutic Targets in Heart Failure","volume":"34","author":"Hanna","year":"2020","journal-title":"Cardiovasc. Drugs Ther."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1161\/CIRCULATIONAHA.118.038010","article-title":"Anti-Inflammatory Therapy with Canakinumab for the Prevention of Hospitalization for Heart Failure","volume":"139","author":"Everett","year":"2019","journal-title":"Circulation"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/FJC.0000000000000591","article-title":"Effect of Interleukin-1 Blockade on Left Ventricular Systolic Performance and Work: A Post Hoc Pooled Analysis of 2 Clinical Trials","volume":"72","author":"Buckley","year":"2018","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_168","first-page":"177","article-title":"Long-term effect of tocilizumab on left ventricular hypertrophy and systolic dysfunction in AA amyloidosis with rheumatoid arthritis","volume":"25","author":"Yamashita","year":"2022","journal-title":"J. Cardiol. Cases"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1002\/hep.29477","article-title":"A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis","volume":"67","author":"Friedman","year":"2018","journal-title":"Hepatology"},{"key":"ref_170","doi-asserted-by":"crossref","unstructured":"Papamichail, A., Kourek, C., Briasoulis, A., Xanthopoulos, A., Tsougos, E., Farmakis, D., and Paraskevaidis, I. (2023). Targeting Key Inflammatory Mechanisms Underlying Heart Failure: A Comprehensive Review. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25010510"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1002\/ehf2.14959","article-title":"IL-6 and hsCRP predict cardiovascular mortality in patients with heart failure with preserved ejection fraction","volume":"11","author":"Berger","year":"2024","journal-title":"ESC Heart Fail."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"E010051","DOI":"10.1161\/CIRCHEARTFAILURE.122.010051","article-title":"Adverse Outcomes Associated with Interleukin-6 in Patients Recently Hospitalized for Heart Failure with Preserved Ejection Fraction","volume":"16","author":"Mooney","year":"2023","journal-title":"Circ. Heart Fail."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"e001633","DOI":"10.1161\/CIRCGENETICS.116.001633","article-title":"Inflammatory Biomarkers Predict Heart Failure Severity and Prognosis in Patients with Heart Failure with Preserved Ejection Fraction: A Holistic Proteomic Approach","volume":"10","author":"Hage","year":"2017","journal-title":"Circ. Cardiovasc. Genet."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jchf.2017.07.013","article-title":"Utility of Growth Differentiation Factor-15, A Marker of Oxidative Stress and Inflammation, in Chronic Heart Failure: Insights from the HF-ACTION Study","volume":"5","author":"Sharma","year":"2017","journal-title":"JACC Heart Fail."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/ehf2.14217","article-title":"Systemic immune-inflammation index as a prognostic marker for advanced chronic heart failure with renal dysfunction","volume":"10","author":"Wang","year":"2023","journal-title":"ESC Heart Fail."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s10741-025-10538-7","article-title":"Targeting inflammation in heart failure: Evolving insights and future directions from randomized clinical trials","volume":"30","author":"Nagasaka","year":"2025","journal-title":"Heart Fail. Rev."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1093\/ntr\/ntae274","article-title":"The Role of Sex in the Effects of Smoking and Nicotine on Cardiovascular Function, Atherosclerosis, and Inflammation","volume":"27","author":"Centner","year":"2025","journal-title":"Nicotine Tob. Res."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1007\/s11606-022-07980-w","article-title":"The Epidemiology of Smoking in Older Adults: A National Cohort Study","volume":"38","author":"Hunt","year":"2023","journal-title":"J. Gen. Intern. Med."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ahj.2012.05.013","article-title":"Cigarette Smoking Exposure and Heart Failure Risk in Older Adults: The Health, Aging, and Body Composition Study","volume":"164","author":"Gopal","year":"2012","journal-title":"Am. Heart J."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.amjcard.2018.04.016","article-title":"Effect of Cigarette Smoking on Risk for Adverse Events in Patients with Heart Failure and Preserved Ejection Fraction","volume":"122","author":"Sandesara","year":"2018","journal-title":"Am. J. Cardiol."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1007\/s00125-018-4725-9","article-title":"Dose-dependent effect of smoking on risk of coronary heart disease, heart failure and stroke in individuals with type 1 diabetes","volume":"61","author":"Feodoroff","year":"2018","journal-title":"Diabetologia"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1161\/CIRCULATIONAHA.117.031912","article-title":"Cigarette Smoking and Incident Heart Failure: Insights from the Jackson Heart Study","volume":"137","author":"Kamimura","year":"2018","journal-title":"Circulation"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1161\/CIRCHEARTFAILURE.114.001885","article-title":"Risk of Heart Failure and Death After Prolonged Smoking Cessation: Role of Amount and Duration of Prior Smoking","volume":"8","author":"Ahmed","year":"2015","journal-title":"Circ. Heart Fail."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.amjcard.2021.12.021","article-title":"Relation of Cigarette Smoking and Heart Failure in Adults \u2265 65 Years of Age (from the Cardiovascular Health Study)","volume":"168","author":"Gottdiener","year":"2022","journal-title":"Am. J. Cardiol."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1016\/j.jacc.2022.03.377","article-title":"Cigarette Smoking, Cessation, and Risk of Heart Failure with Preserved and Reduced Ejection Fraction","volume":"79","author":"Ding","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_186","doi-asserted-by":"crossref","unstructured":"Polecka, A., Olszewska, N., Danielski, \u0141., and Olszewska, E. (2023). Association between Obstructive Sleep Apnea and Heart Failure in Adults-A Systematic Review. J. Clin. Med., 12.","DOI":"10.3390\/jcm12196139"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.cardfail.2020.06.007","article-title":"In-Hospital Management of Sleep Apnea During Heart Failure Hospitalization: A Randomized Controlled Trial","volume":"26","author":"Khayat","year":"2020","journal-title":"J. Card. Fail."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1093\/eurheartj\/ehu522","article-title":"Sleep disordered breathing and post-discharge mortality in patients with acute heart failure","volume":"36","author":"Khayat","year":"2015","journal-title":"Eur. Heart J."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/clc.22738","article-title":"Obstructive sleep apnea is associated with increased readmission in heart failure patients","volume":"40","author":"Sommerfeld","year":"2017","journal-title":"Clin. Cardiol."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"E002814","DOI":"10.1161\/CIRCGEN.119.002814","article-title":"Alcohol Consumption and Cardiovascular Disease: A Mendelian Randomization Study","volume":"13","author":"Larsson","year":"2020","journal-title":"Circ. Genom. Precis. Med."},{"key":"ref_191","doi-asserted-by":"crossref","unstructured":"Yeo, Y., Jeong, S.M., Shin, D.W., Han, K., Yoo, J., Yoo, J.E., and Lee, S.P. (2022). Changes in Alcohol Consumption and Risk of Heart Failure: A Nationwide Population-Based Study in Korea. Int. J. Environ. Res. Public Health, 19.","DOI":"10.3390\/ijerph192316265"},{"key":"ref_192","doi-asserted-by":"crossref","unstructured":"Nguyen, X.M.T., Elhouderi, E., Li, Y., Williams, A.R., Gaziano, L., Joseph, J., Gaziano, J.M., Cho, K., and Djousse, L. (2026). Alcohol Intake and Incidence of Heart Failure and Its Subtypes: VA Million Veteran Program. Nutrients, 18.","DOI":"10.3390\/nu18030471"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.amjcard.2005.03.073","article-title":"Alcohol drinking and risk of hospitalization for heart failure with and without associated coronary artery disease","volume":"96","author":"Klatsky","year":"2005","journal-title":"Am. J. Cardiol."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1001\/jama.285.15.1971","article-title":"Moderate alcohol consumption and risk of heart failure among older persons","volume":"285","author":"Abramson","year":"2001","journal-title":"JAMA"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"181","DOI":"10.7326\/0003-4819-136-3-200202050-00005","article-title":"Alcohol consumption and risk for congestive heart failure in the Framingham Heart Study","volume":"136","author":"Walsh","year":"2002","journal-title":"Ann. Intern. Med."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1161\/HHF.0b013e318291329a","article-title":"Forecasting the Impact of Heart Failure in the United States: A Policy Statement from the American Heart Association","volume":"6","author":"Heidenreich","year":"2013","journal-title":"Circ. Heart Fail."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/s41591-021-01659-1","article-title":"The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: A multinational randomized trial","volume":"28","author":"Voors","year":"2022","journal-title":"Nat. Med."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","article-title":"Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: The CHARM-Preserved Trial","volume":"362","author":"Yusuf","year":"2003","journal-title":"Lancet"}],"updated-by":[{"DOI":"10.3390\/ijms27146160","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000}}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/12\/5296\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T12:54:11Z","timestamp":1783688051000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/12\/5296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":198,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["ijms27125296"],"URL":"https:\/\/doi.org\/10.3390\/ijms27125296","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,11]]}}}